Obicetrapib lowers LDL-C in patients on high intensity statins: Results from the rose trial (NCT04753606)
| Autor: | Ray, K.K. 1, Nicholls, S. 2, Ditmarsch, M. 3, Kastelein, J.J. 4, Rigby, S. 5, Kling, D. 6, Curcio, D. 7, Alp, N. 8, Davidson, M. 9 |
|---|---|
| Zdroj: | In Atherosclerosis August 2022 355 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect